Copyright Reports & Markets. All rights reserved.

Global Microbial Fermentation APIs Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Microbial Fermentation APIs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Microbial Fermentation APIs Market Size Growth Rate by Type
    • 1.4.2 Antibiotics
    • 1.4.3 Amino Acids
    • 1.2.4 Vitamin
    • 1.2.5 Nucleotide
    • 1.2.6 Organic Acid
    • 1.2.7 Alcohol
    • 1.2.8 Biological Products
    • 1.2.9 Hormone
  • 1.3 Market by Application
    • 1.3.1 Global Microbial Fermentation APIs Market Size Growth Rate by Application
    • 1.3.2 Hospitals
    • 1.3.3 Research & Academic Laboratories
    • 1.3.4 Pharmaceutical & Biotechnology Companies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Microbial Fermentation APIs Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Microbial Fermentation APIs Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Microbial Fermentation APIs Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Microbial Fermentation APIs Regions by Sales
    • 2.4.1 Global Top Microbial Fermentation APIs Regions by Sales (2016-2021)
    • 2.4.2 Global Top Microbial Fermentation APIs Regions by Sales (2022-2027)
  • 2.5 Global Top Microbial Fermentation APIs Regions by Revenue
    • 2.5.1 Global Top Microbial Fermentation APIs Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Microbial Fermentation APIs Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Microbial Fermentation APIs Sales by Manufacturers
    • 3.1.1 Global Top Microbial Fermentation APIs Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Microbial Fermentation APIs Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Microbial Fermentation APIs Sales in 2020
  • 3.2 Global Microbial Fermentation APIs Revenue by Manufacturers
    • 3.2.1 Global Top Microbial Fermentation APIs Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Microbial Fermentation APIs Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Microbial Fermentation APIs Revenue in 2020
  • 3.3 Global Microbial Fermentation APIs Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Microbial Fermentation APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Microbial Fermentation APIs Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Microbial Fermentation APIs Sales by Type
    • 4.1.1 Global Microbial Fermentation APIs Historical Sales by Type (2016-2021)
    • 4.1.2 Global Microbial Fermentation APIs Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Microbial Fermentation APIs Sales Market Share by Type (2016-2027)
  • 4.2 Global Microbial Fermentation APIs Revenue by Type
    • 4.2.1 Global Microbial Fermentation APIs Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Microbial Fermentation APIs Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Microbial Fermentation APIs Revenue Market Share by Type (2016-2027)
  • 4.3 Global Microbial Fermentation APIs Price by Type
    • 4.3.1 Global Microbial Fermentation APIs Price by Type (2016-2021)
    • 4.3.2 Global Microbial Fermentation APIs Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Microbial Fermentation APIs Sales by Application
    • 5.1.1 Global Microbial Fermentation APIs Historical Sales by Application (2016-2021)
    • 5.1.2 Global Microbial Fermentation APIs Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Microbial Fermentation APIs Sales Market Share by Application (2016-2027)
  • 5.2 Global Microbial Fermentation APIs Revenue by Application
    • 5.2.1 Global Microbial Fermentation APIs Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Microbial Fermentation APIs Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Microbial Fermentation APIs Revenue Market Share by Application (2016-2027)
  • 5.3 Global Microbial Fermentation APIs Price by Application
    • 5.3.1 Global Microbial Fermentation APIs Price by Application (2016-2021)
    • 5.3.2 Global Microbial Fermentation APIs Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Microbial Fermentation APIs Market Size by Type
    • 6.1.1 North America Microbial Fermentation APIs Sales by Type (2016-2027)
    • 6.1.2 North America Microbial Fermentation APIs Revenue by Type (2016-2027)
  • 6.2 North America Microbial Fermentation APIs Market Size by Application
    • 6.2.1 North America Microbial Fermentation APIs Sales by Application (2016-2027)
    • 6.2.2 North America Microbial Fermentation APIs Revenue by Application (2016-2027)
  • 6.3 North America Microbial Fermentation APIs Market Size by Country
    • 6.3.1 North America Microbial Fermentation APIs Sales by Country (2016-2027)
    • 6.3.2 North America Microbial Fermentation APIs Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Microbial Fermentation APIs Market Size by Type
    • 7.1.1 Europe Microbial Fermentation APIs Sales by Type (2017-2027)
    • 7.1.2 Europe Microbial Fermentation APIs Revenue by Type (2017-2027)
  • 7.2 Europe Microbial Fermentation APIs Market Size by Application
    • 7.2.1 Europe Microbial Fermentation APIs Sales by Application (2017-2027)
    • 7.2.2 Europe Microbial Fermentation APIs Revenue by Application (2017-2027)
  • 7.3 Europe Microbial Fermentation APIs Market Size by Country
    • 7.3.1 Europe Microbial Fermentation APIs Sales by Country (2017-2027)
    • 7.3.2 Europe Microbial Fermentation APIs Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Microbial Fermentation APIs Market Size by Type
    • 8.1.1 Asia Pacific Microbial Fermentation APIs Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Microbial Fermentation APIs Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Microbial Fermentation APIs Market Size by Application
    • 8.2.1 Asia Pacific Microbial Fermentation APIs Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Microbial Fermentation APIs Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Microbial Fermentation APIs Market Size by Region
    • 8.3.1 Asia Pacific Microbial Fermentation APIs Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Microbial Fermentation APIs Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Microbial Fermentation APIs Market Size by Type
    • 9.1.1 Latin America Microbial Fermentation APIs Sales by Type (2019-2027)
    • 9.1.2 Latin America Microbial Fermentation APIs Revenue by Type (2019-2027)
  • 9.2 Latin America Microbial Fermentation APIs Market Size by Application
    • 9.2.1 Latin America Microbial Fermentation APIs Sales by Application (2019-2027)
    • 9.2.2 Latin America Microbial Fermentation APIs Revenue by Application (2019-2027)
  • 9.3 Latin America Microbial Fermentation APIs Market Size by Country
    • 9.3.1 Latin America Microbial Fermentation APIs Sales by Country (2019-2027)
    • 9.3.2 Latin America Microbial Fermentation APIs Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Microbial Fermentation APIs Market Size by Type
    • 6.1.1 Middle East and Africa Microbial Fermentation APIs Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Microbial Fermentation APIs Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Microbial Fermentation APIs Market Size by Application
    • 6.2.1 Middle East and Africa Microbial Fermentation APIs Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Microbial Fermentation APIs Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Microbial Fermentation APIs Market Size by Country
    • 6.3.1 Middle East and Africa Microbial Fermentation APIs Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Microbial Fermentation APIs Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Overview
    • 11.1.3 Merck Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Merck Microbial Fermentation APIs Product Description
    • 11.1.5 Merck Related Developments
  • 11.2 Ajinomoto
    • 11.2.1 Ajinomoto Corporation Information
    • 11.2.2 Ajinomoto Overview
    • 11.2.3 Ajinomoto Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Ajinomoto Microbial Fermentation APIs Product Description
    • 11.2.5 Ajinomoto Related Developments
  • 11.3 HGPF
    • 11.3.1 HGPF Corporation Information
    • 11.3.2 HGPF Overview
    • 11.3.3 HGPF Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 HGPF Microbial Fermentation APIs Product Description
    • 11.3.5 HGPF Related Developments
  • 11.4 Huaxing
    • 11.4.1 Huaxing Corporation Information
    • 11.4.2 Huaxing Overview
    • 11.4.3 Huaxing Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Huaxing Microbial Fermentation APIs Product Description
    • 11.4.5 Huaxing Related Developments
  • 11.5 North China Pharmaceutical
    • 11.5.1 North China Pharmaceutical Corporation Information
    • 11.5.2 North China Pharmaceutical Overview
    • 11.5.3 North China Pharmaceutical Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 North China Pharmaceutical Microbial Fermentation APIs Product Description
    • 11.5.5 North China Pharmaceutical Related Developments
  • 11.6 Topfond
    • 11.6.1 Topfond Corporation Information
    • 11.6.2 Topfond Overview
    • 11.6.3 Topfond Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Topfond Microbial Fermentation APIs Product Description
    • 11.6.5 Topfond Related Developments
  • 11.7 DSM
    • 11.7.1 DSM Corporation Information
    • 11.7.2 DSM Overview
    • 11.7.3 DSM Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 DSM Microbial Fermentation APIs Product Description
    • 11.7.5 DSM Related Developments
  • 11.8 Tianyao
    • 11.8.1 Tianyao Corporation Information
    • 11.8.2 Tianyao Overview
    • 11.8.3 Tianyao Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Tianyao Microbial Fermentation APIs Product Description
    • 11.8.5 Tianyao Related Developments
  • 11.9 CSPC Pharma
    • 11.9.1 CSPC Pharma Corporation Information
    • 11.9.2 CSPC Pharma Overview
    • 11.9.3 CSPC Pharma Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 CSPC Pharma Microbial Fermentation APIs Product Description
    • 11.9.5 CSPC Pharma Related Developments
  • 11.10 Northeast Pharm
    • 11.10.1 Northeast Pharm Corporation Information
    • 11.10.2 Northeast Pharm Overview
    • 11.10.3 Northeast Pharm Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Northeast Pharm Microbial Fermentation APIs Product Description
    • 11.10.5 Northeast Pharm Related Developments
  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Overview
    • 11.1.3 Merck Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Merck Microbial Fermentation APIs Product Description
    • 11.1.5 Merck Related Developments
  • 11.12 Luwei Pharmaceutical
    • 11.12.1 Luwei Pharmaceutical Corporation Information
    • 11.12.2 Luwei Pharmaceutical Overview
    • 11.12.3 Luwei Pharmaceutical Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Luwei Pharmaceutical Product Description
    • 11.12.5 Luwei Pharmaceutical Related Developments
  • 11.13 Jiangshan (DSM)
    • 11.13.1 Jiangshan (DSM) Corporation Information
    • 11.13.2 Jiangshan (DSM) Overview
    • 11.13.3 Jiangshan (DSM) Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.13.4 Jiangshan (DSM) Product Description
    • 11.13.5 Jiangshan (DSM) Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Microbial Fermentation APIs Value Chain Analysis
  • 12.2 Microbial Fermentation APIs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Microbial Fermentation APIs Production Mode & Process
  • 12.4 Microbial Fermentation APIs Sales and Marketing
    • 12.4.1 Microbial Fermentation APIs Sales Channels
    • 12.4.2 Microbial Fermentation APIs Distributors
  • 12.5 Microbial Fermentation APIs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Microbial Fermentation APIs Industry Trends
  • 13.2 Microbial Fermentation APIs Market Drivers
  • 13.3 Microbial Fermentation APIs Market Challenges
  • 13.4 Microbial Fermentation APIs Market Restraints

14 Key Findings in The Global Microbial Fermentation APIs Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Microbial Fermentation APIs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Microbial Fermentation APIs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Antibiotics
    Amino Acids
    Vitamin
    Nucleotide
    Organic Acid
    Alcohol
    Biological Products
    Hormone

    Segment by Application
    Hospitals
    Research & Academic Laboratories
    Pharmaceutical & Biotechnology Companies

    By Company
    Merck
    Ajinomoto
    HGPF
    Huaxing
    North China Pharmaceutical
    Topfond
    DSM
    Tianyao
    CSPC Pharma
    Northeast Pharm
    Lukang Pharmaceutical
    Luwei Pharmaceutical
    Jiangshan (DSM)

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now